DUBLIN–(BUSINESS WIRE)–Mar 17, 2021–
The “Lewy Body Dementia Treatment Market Share, Size, Trends, Industry Analysis Report, By Drug Type; By Indication; By Distribution Channel; By Regions Segment Forecast, 2020-2027” report has been added to ResearchAndMarkets.com‘s providing.
The international Lewy physique dementia remedy market dimension is predicted to attain USD 5.31 billion by 2027. This report offers an in depth perception into present market dynamics and supplies evaluation on future market development.
Lewy physique dementia is a progressive dysfunction related to dysfunction of the central nervous system and characterised by deposits of alpha-synuclein, a protein within the mind. The uncommon deposits within the mind shaped Lewy our bodies, which may lead to a number of issues with physique motion, pondering, temper, and conduct. Lewy physique dementia is the most typical illness after Alzheimer’s which is quickly rising and subsequently foster international market development. Recent developments embrace the brand new launches and scientific research corresponding to LY3154207, ABBV-0805, and so forth. The launches of medication are related to the prognosis of dementia with Lewy physique, Parkinson’s, and Alzheimer’s ailments which additional leads to drive the expansion of the worldwide market.
The distinguished components favoring the worldwide market development embrace the rising initiatives by the authorized and regulatory authorities to develop an efficient and protected remedy for the LBD dysfunction within the sufferers. For occasion, in October 2019, an LBD Association Research Center of Excellence, Georgetown University Medical Center, has taken the initiative to supply 3 scientific trials to devise new strategies and therapies for Lewy physique dementia and Alzheimer’s illness.
Rising incidences of getting affected by Alzheimer’s illness and associated issues embrace vascular dementia, Lewy physique dementia, frontotemporal degeneration, and Parkinson’s illness has witnessed the surge in demand for the remedy of the sufferers. The regulatory authorities and researchers are engaged in discovering new strategies and options to present efficient remedy of the dysfunction.
For occasion, in June 2020, The Harry T. Mangurian, Jr. Foundation and Florida Atlantic University’s Schmidt College of Medicine have amalgamated its forces to uncover and analysis medication to forestall dementia. The grant of USD 3 million will enable FAU’s Schmidt College of Medicine to set up a brand new FAU Center for Brain Health. Furthermore, in July 2020, the Journal of the American Medical Association (JAMA) has printed that researchers have shaped a brand new p-tau217 blood take a look at, which is proved to maintain exceptional leads to the prognosis of Alzheimer’s illness and associated issues within the sufferers.
Additionally, the rising prevalence of the progressive ailments of dementia has raised the necessity for efficient remedy to deal with the illness and forestall threat within the sufferers which additional leads to drive development. The rising consciousness of the signs of the illness and the development in healthcare know-how to develop new strategies and medicine for the remedy of sufferers is probably going to surge the market development.
- Mallinckrodt Pharmaceuticals
- BioArctic AB
- Bausch Health Companies Inc.
- Sumitomo Dainippon Pharma Co. Ltd.
- Janssen Pharmaceuticals Inc.
- Jazz Pharmaceuticals Inc.
- Allergan Plc.
- Noven Pharmaceuticals Inc.
- Takeda Pharmaceutical Company Ltd.
- Eli Lilly and Company
- Eisai Co. Ltd.
- Novartis AG
- Pfizer Inc.
- Teva Pharmaceuticals
- Bayer AG
- Sanofi AG
- Mylan NV
Key Topics Covered:
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. Lewy Body Dementia Treatment Market Insights
4.1. Lewy Body Dementia Treatment – Industry snapshot
4.2. Lewy Body Dementia Treatment Market Dynamics
4.2.1. Drivers and Opportunities
18.104.22.168. Prevalence of Lewy physique dementia
22.214.171.124. Affordable Treatment Options
4.2.2. Restraints and Challenges
126.96.36.199. Drug facet-results
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Lewy Body Dementia Treatment Market Industry traits
5. Lewy Body Dementia Treatment Market Assessment by Drug Type
5.1. Key Findings
5.4. Cholinesterase Inhibitors
5.6. Antipsychotic Drugs
6. Lewy Body Dementia Treatment Market Assessment by Indication
6.1. Key Findings
6.3. Parkinson’s Disease
6.4. Dementia with Lewy Bodies (DLB)
7. Lewy Body Dementia Treatment Market Assessment by Distribution Channel
7.1. Key Findings
7.3. Drug Stores
7.4. Hospitals Pharmacies
7.5. Online Pharmacies
7.6. Retail Pharmacies
8. Lewy Body Dementia Treatment Market Assessment by Geography
8.1. Key findings
8.3. Lewy Body Dementia Treatment Market – North America
8.4. Lewy Body Dementia Treatment Market – Europe
8.5. Lewy Body Dementia Treatment Market – Asia-Pacific
8.6. Lewy Body Dementia Treatment Market – Middle East & Africa
8.7. Lewy Body Dementia Treatment Market – Latin America
9. Competitive Landscape
9.1. Expansion and Acquisition Analysis
10. Company Profiles
For extra details about this report go to https://www.researchandmarkets.com/r/l0uuxk
View supply model on businesswire.com:https://www.businesswire.com/news/home/20210317005387/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: GENERAL HEALTH PHARMACEUTICAL HEALTH OTHER HEALTH
SOURCE: Research and Markets
Copyright Business Wire 2021.
PUB: 03/17/2021 05:42 AM/DISC: 03/17/2021 05:42 AM
Copyright Business Wire 2021.